AtriCure
ATRC
AtriCure (ATRC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Overweight | $60.00 from $50.00 | Aug 27, 2026 |
| BTIG | Maintained | Buy | $55.00 from $45.00 | Aug 24, 2026 |
| UBS | Maintained | Buy | $50.00 from $55.00 | Jul 28, 2026 |
| Canaccord Genuity | Maintained | Buy | $55.00 from $53.00 | May 6, 2026 |
| Oppenheimer | Downgraded | Outperform → Perform | — | Feb 18, 2026 |
| UBS | Maintained | Buy | $55.00 from $60.00 | Feb 18, 2026 |
| BTIG | Maintained | Buy | $54.00 | Feb 18, 2026 |
| Canaccord Genuity | Maintained | Buy | $53.00 from $64.00 | Feb 18, 2026 |
| Citizens | Maintained | Market Outperform | $52.00 from $60.00 | Feb 18, 2026 |
| Needham | Maintained | Buy | $45.00 | Feb 12, 2026 |
| JP Morgan | Maintained | Overweight | $48.00 from $42.00 | Dec 16, 2025 |
| Canaccord Genuity | Maintained | Buy | $64.00 from $53.00 | Oct 30, 2025 |
| Needham | Maintained | Buy | $45.00 from $44.00 | Jul 30, 2025 |
| Needham | Maintained | Buy | $44.00 from $51.00 | Apr 30, 2025 |
| UBS | Maintained | Buy | $58.00 from $60.00 | Apr 30, 2025 |
| JMP Securities | Maintained | Market Outperform | $60.00 | Apr 30, 2025 |
| Citizens Capital Markets | Maintained | Market Outperform | $60.00 | Apr 2, 2025 |
| Canaccord Genuity | Maintained | Buy | $52.00 from $66.00 | Mar 28, 2025 |
| Needham | Maintained | Buy | $51.00 | Mar 27, 2025 |
| JP Morgan | Maintained | Overweight | $46.00 from $51.00 | Mar 27, 2025 |
Frequently asked questions
What is the latest analyst rating on ATRC?
On Aug 27, 2026, Piper Sandler maintained AtriCure at Overweight with a price target of $60.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.